New uses of Mirogabalin claimed by Daiichi... May 17
Daiichi Sankyo will use undiluted solutions provided by AstraZeneca to manufacture COVID-19 vaccines in Japan... Feb 10
In the US, gastric cancer is most frequently diagnosed in the advanced stage, with only approximately 5% of patients surviving beyond five years.... Jan 18
Another USFDA approval for Lupin... Dec 18
The impact of the disease is significant, with breast cancer responsible for more than 137,000 deaths per year.... Dec 14
Enhertu continued to demonstrate impressive efficacy and durable responses in patients with HER2-positive metastatic breast cancer following two or more prior HER2-based regimens.... Dec 10
Only HER2-directed medicine to demonstrate significant improvement in overall survival compared to chemotherapy... Oct 28
RAIN-32 is a potent and selective MDM2 inhibitor that has been evaluated in clinical trials for solid tumors and hematologic malignancies... Sep 03
Two pharma giants come together for developing Global Companion Diagnostics for patients with NSCLC cancer... Jun 25
VerifyMe and Techind will work together in providing the VeriPAS(TM) serialization... Jun 16
-Advertisements-
Friday, June 14, 2024
